Sh. Zaman et al., Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine, NEUROBIOL D, 7(1), 2000, pp. 54-63
Mutations in presenilin 1(PS1) are the most common causes of familial Alzhe
imer's disease (FAD). We examined synaptic physiology in hippocampal brain
slices of transgenic mice expressing the FAD-linked PS1 deletion of exon 9
variant. Basal excitatory transmission and paired-pulse facilitation in PS1
mutant mice were unchanged. Short- and long-term potentiation of excitator
y transmission following high-frequency stimulation were greater in transge
nic mice expressing mutant PS1. Mutants had enhanced synaptic inhibition, w
hich may be a compensatory change offsetting an abnormally sensitized plast
icity of excitatory transmission. Increasing inhibitory transmission in mut
ant animals even more with a benzodiazepine reverted synaptic potentiation
to the levels of controls. These results support the potential use of benzo
diazepines in the treatment of familial Alzheimer's disease. (C) 2000 Acade
mic Press.